0001437749-17-006827.txt : 20170419
0001437749-17-006827.hdr.sgml : 20170419
20170419213918
ACCESSION NUMBER: 0001437749-17-006827
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170417
FILED AS OF DATE: 20170419
DATE AS OF CHANGE: 20170419
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUTERA INC
CENTRAL INDEX KEY: 0001162461
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 770492262
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3240 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 94005
MAIL ADDRESS:
STREET 1: 3240 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: ALTUS MEDICAL INC
DATE OF NAME CHANGE: 20011119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Laber Larry
CENTRAL INDEX KEY: 0001697193
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50644
FILM NUMBER: 17771203
MAIL ADDRESS:
STREET 1: C/O CUTERA, INC.
STREET 2: 3240 BAYSHORE BLVD
CITY: BRISBANE
STATE: CA
ZIP: 94005
4
1
rdgdoc.xml
FORM 4-LL
X0306
4
2017-04-17
0001162461
CUTERA INC
CUTR
0001697193
Laber Larry
C/O CUTERA, INC.
3240 BAYSHORE BLVD
BRISBANE
CA
94005
1
EVP, North America Sales
COMMON
2017-04-17
4
M
0
2076
10.03
A
78852
D
COMMON
2017-04-17
4
S
0
2076
20.54
A
76776
D
COMMON
2017-04-19
4
M
0
100
10.03
A
76876
D
COMMON
2017-04-19
4
S
0
100
20.50
A
76776
D
Employee Stock Option (Right to Buy)
10.03
2017-04-17
4
M
0
2076
0
D
2015-09-11
2021-10-24
Common Stock
30000
27924
D
Employee Stock Option (Right to Buy)
10.03
2017-04-19
4
M
0
100
0
D
2015-09-11
2021-10-24
Common Stock
30000
27824
D
Stock sold pursuant to a 10b5-1 trading plan.
Stock sold in open market transactions pursuant to a 10b5-1 plan at prices that ranged from $20.50 to $20.65 with $20.54 being the average. The reporting person undertakes to provide to Cutera, Inc., any security holder of Cutera, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ Larry Laber
2017-04-19